NCT00455442View on ClinicalTrials.gov

A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

July 31, 2007

Conditions
Weight-Gain Prevention
Interventions
DRUG

Mifepristone

Trial Locations (1)

Unknown

St. John's Medical College, Bangalore

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Corcept Therapeutics

INDUSTRY